Best Choice — Class II drug recall D-0157-2021
Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2020-12-23, distributed nationwide. Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the
| Recall number | D-0157-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States |
| Recall initiated | 2020-11-17 |
| Classified | 2020-12-16 |
| Reported by FDA | 2020-12-23 |
| Terminated | 2024-02-21 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 11,088 |
| Reason classes | specification failure |
| UPC / GTIN / UDI-DI | 00070038203551 |
| Lot numbers | 200, 2021, 252, D867331087 |
Product
Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1
Reason for recall
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0157-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.